| mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.033 |
0.9 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |